BioCentury | Oct 3, 2020
Management Tracks

Li to guide Merck’s next wave of cancer therapies launched by Perlmutter

Dean Li will take over a Merck Research Laboratories that has been transformed by Roger Perlmutter over the past seven years, guiding a pharma that had been struggling with a patent cliff to the company...
BioCentury | Jun 9, 2016
Distillery Therapeutics

Therapeutics: ADP-ribosylation factor 6 (ARF6); G protein q polypeptide (GNAQ; G-ALPHA-q)

Cancer INDICATION: Melanoma Cell culture and mouse studies suggest inhibiting ARF6 could help treat GNAQ-mutant uveal melanoma. In two human GNAQ-mutant uveal melanoma cell lines, siRNA targeting ARF6 decreased colony-forming units and proliferation compared with...
BioCentury | Apr 15, 2013
Company News

Verinata management update

...development at Affymetrix Inc. ; and Vance Vanier as president, formerly president and CEO of Navigenics Inc....
BioCentury | Jan 21, 2013
Finance

Genetics for docs

...digest lengthy reports - they want the answer," he added. Stephan previously founded genomics company Navigenics Inc....
BioCentury | Jan 21, 2013
Company News

Silicon Valley Biosystems diagnostic news

...Harvard Medical School and Boston Children's Hospital . He was also founder and CSO of Navigenics Inc....
BioCentury | Oct 15, 2012
Finance

Highlights of weekly biotech stock moves

...into cancer diagnostics that began in July with the acquisitions of Pinpoint Genomics Inc. and Navigenics Inc....
BioCentury | Oct 15, 2012
Company News

Compendia Bioscience, Life Technologies deal

...into cancer diagnostics, which began in July with the acquisitions of Pinpoint Genomics Inc. and Navigenics Inc....
BioCentury | Oct 9, 2012
Company News

Life Tech acquires bioinformatics firm Compendia

...into cancer diagnostics, which began in July with the acquisitions of Pinpoint Genomics Inc. and Navigenics Inc....
BioCentury | Sep 13, 2012
Cover Story

VEGF reflects on itself

North American researchers have chemically synthesized a d-protein ligand that blocked the binding of VEGF to its receptor in vitro . 1 Reflexion Pharmaceuticals Inc. has licensed the compound and thinks it could have better stability...
BioCentury | Jul 23, 2012
Company News

Life Technologies, Navigenics deal

...Life Technologies acquired Navigenics for an undisclosed sum. Life Technologies said Navigenics' CLIA-certified laboratory will allow...
...out" its molecular diagnostics business. Details were not disclosed. Life Technologies Corp. (NASDAQ:LIFE), Carlsbad, Calif. Navigenics Inc....
Items per page:
1 - 10 of 27
BioCentury | Oct 3, 2020
Management Tracks

Li to guide Merck’s next wave of cancer therapies launched by Perlmutter

Dean Li will take over a Merck Research Laboratories that has been transformed by Roger Perlmutter over the past seven years, guiding a pharma that had been struggling with a patent cliff to the company...
BioCentury | Jun 9, 2016
Distillery Therapeutics

Therapeutics: ADP-ribosylation factor 6 (ARF6); G protein q polypeptide (GNAQ; G-ALPHA-q)

Cancer INDICATION: Melanoma Cell culture and mouse studies suggest inhibiting ARF6 could help treat GNAQ-mutant uveal melanoma. In two human GNAQ-mutant uveal melanoma cell lines, siRNA targeting ARF6 decreased colony-forming units and proliferation compared with...
BioCentury | Apr 15, 2013
Company News

Verinata management update

...development at Affymetrix Inc. ; and Vance Vanier as president, formerly president and CEO of Navigenics Inc....
BioCentury | Jan 21, 2013
Finance

Genetics for docs

...digest lengthy reports - they want the answer," he added. Stephan previously founded genomics company Navigenics Inc....
BioCentury | Jan 21, 2013
Company News

Silicon Valley Biosystems diagnostic news

...Harvard Medical School and Boston Children's Hospital . He was also founder and CSO of Navigenics Inc....
BioCentury | Oct 15, 2012
Finance

Highlights of weekly biotech stock moves

...into cancer diagnostics that began in July with the acquisitions of Pinpoint Genomics Inc. and Navigenics Inc....
BioCentury | Oct 15, 2012
Company News

Compendia Bioscience, Life Technologies deal

...into cancer diagnostics, which began in July with the acquisitions of Pinpoint Genomics Inc. and Navigenics Inc....
BioCentury | Oct 9, 2012
Company News

Life Tech acquires bioinformatics firm Compendia

...into cancer diagnostics, which began in July with the acquisitions of Pinpoint Genomics Inc. and Navigenics Inc....
BioCentury | Sep 13, 2012
Cover Story

VEGF reflects on itself

North American researchers have chemically synthesized a d-protein ligand that blocked the binding of VEGF to its receptor in vitro . 1 Reflexion Pharmaceuticals Inc. has licensed the compound and thinks it could have better stability...
BioCentury | Jul 23, 2012
Company News

Life Technologies, Navigenics deal

...Life Technologies acquired Navigenics for an undisclosed sum. Life Technologies said Navigenics' CLIA-certified laboratory will allow...
...out" its molecular diagnostics business. Details were not disclosed. Life Technologies Corp. (NASDAQ:LIFE), Carlsbad, Calif. Navigenics Inc....
Items per page:
1 - 10 of 27